Cargando…

The PI3K Inhibitor XH30 Enhances Response to Temozolomide in Drug-Resistant Glioblastoma via the Noncanonical Hedgehog Signaling Pathway

Glioblastoma multiforme (GBM) is the most common malignant tumor of the central nervous system. Temozolomide (TMZ)–based adjuvant treatment has improved overall survival, but clinical outcomes remain poor; TMZ resistance is one of the main reasons for this. Here, we report a new phosphatidylinositid...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ji, Ming, Zhang, Zhihui, Lin, Songwen, Wang, Chunyang, Jin, Jing, Xue, Nina, Xu, Heng, Chen, Xiaoguang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8662317/ https://www.ncbi.nlm.nih.gov/pubmed/34899305 http://dx.doi.org/10.3389/fphar.2021.749242

Ejemplares similares

A novel PI3K inhibitor XH30 suppresses orthotopic glioblastoma and brain metastasis in mice models
por: Ji, Ming, et al.
Publicado: (2022)

A Dual PI3K/HDAC Inhibitor Downregulates Oncogenic Pathways in Hematologic Tumors In Vitro and In Vivo
por: Yan, Zheng, et al.
Publicado: (2021)

The New PI3K/mTOR Inhibitor GNE-477 Inhibits the Malignant Behavior of Human Glioblastoma Cells
por: Wang, Yixuan, et al.
Publicado: (2021)

Modified Adenosines Sensitize Glioblastoma Cells to Temozolomide by Affecting DNA Methyltransferases
por: Proto, Maria Chiara, et al.
Publicado: (2022)

Aberrant Expression of ADARB1 Facilitates Temozolomide Chemoresistance and Immune Infiltration in Glioblastoma
por: Lu, Can, et al.
Publicado: (2022)

CAT(3), a prodrug of 13a(S)-3-hydroxyl-6,7-dimethoxyphenanthro[9,10-b]-indolizidine, circumvents temozolomide-resistant glioblastoma via the Hedgehog signaling pathway, independently of O(6)-methylguanine DNA methyltransferase expression
por: Ji, Ming, et al.
Publicado: (2018)

Investigating the role of Hedgehog/GLI1 signaling in glioblastoma cell response to temozolomide
por: Melamed, Jilian R., et al.
Publicado: (2018)

Desert Hedgehog/Patch2 Axis Contributes to Vascular Permeability and Angiogenesis in Glioblastoma
por: Azzi, Sandy, et al.
Publicado: (2015)

Abnormally Expressed Ferroptosis-Associated FANCD2 in Mediating the Temozolomide Resistance and Immune Response in Glioblastoma
por: Song, Liying, et al.
Publicado: (2022)

Polydopamine-based loaded temozolomide nanoparticles conjugated by peptide-1 for glioblastoma chemotherapy and photothermal therapy
por: Wu, Hao, et al.
Publicado: (2023)

Temozolomide hexadecyl ester targeted plga nanoparticles for drug-resistant glioblastoma therapy via intranasal administration
por: Wang, Siqi, et al.
Publicado: (2022)

Dual XH–π Interaction of Hexafluoroisopropanol with Arenes
por: Lu, Le, et al.
Publicado: (2021)

Hedgehog/Gli1 signaling pathway regulates MGMT expression and chemoresistance to temozolomide in human glioblastoma
por: Wang, Ke, et al.
Publicado: (2017)

Noncanonical Sonic Hedgehog signaling amplifies platelet reactivity and thrombogenicity
por: Tiwari, Arundhati, et al.
Publicado: (2022)

Phytochemicals and PI3K Inhibitors in Cancer—An Insight
por: Suvarna, Vasanti, et al.
Publicado: (2017)

Motile cilia of human airway epithelia contain hedgehog signaling components that mediate noncanonical hedgehog signaling
por: Mao, Suifang, et al.
Publicado: (2018)

Cycling Quiescence in Temozolomide Resistant Glioblastoma Cells Is Partly Explained by microRNA-93 and -193-Mediated Decrease of Cyclin D
por: Munoz, Jessian L., et al.
Publicado: (2019)

Canonical Hedgehog Pathway and Noncanonical GLI Transcription Factor Activation in Cancer
por: Suchors, Chamey, et al.
Publicado: (2022)

Cost-Effectiveness of Short-Course Radiation Plus Temozolomide for the Treatment of Newly Diagnosed Glioblastoma Among Elderly Patients in China and the United States
por: Chen, Jigang, et al.
Publicado: (2021)

Temozolomide resistance in glioblastoma occurs by miRNA-9-targeted PTCH1, independent of sonic hedgehog level
por: Munoz, Jessian L., et al.
Publicado: (2015)

Complete Genome Sequence of Streptococcus gallolyticus Strain XH2168
por: Yang, Siyuan, et al.
Publicado: (2023)

Unraveling the therapeutic potential of the LncRNA-dependent noncanonical Hedgehog pathway in cancer
por: Xing, Zhen, et al.
Publicado: (2015)

Comparing PI3K/Akt Inhibitors Used in Ovarian Cancer Treatment
por: Wu, Yi-Hui, et al.
Publicado: (2020)

Kanglexin protects against cardiac fibrosis and dysfunction in mice by TGF-β1/ERK1/2 noncanonical pathway
por: Liu, Xue, et al.
Publicado: (2021)

In vitro nuclear magnetic resonance spectroscopy metabolic biomarkers for the combination of temozolomide with PI3K inhibition in paediatric glioblastoma cells
por: Al-Saffar, Nada M. S., et al.
Publicado: (2017)

Hypolipidemic effect of XH601 on hamsters of Hyperlipidemia and its potential mechanism
por: Zhao, Meng-Jie, et al.
Publicado: (2017)

The protective effects of XH‐105 against radiation‐induced intestinal injury
por: Cheng, Ying, et al.
Publicado: (2019)

Butanol–isopropanol fermentation with oxygen-tolerant Clostridium beijerinckii XH29
por: Yao, Xiuqing, et al.
Publicado: (2022)

Interacting Quantum Atoms and Multipolar Electrostatic Study of XH···π Interactions
por: Triestram, Lena, et al.
Publicado: (2023)

Temozolomide resistance in glioblastoma multiforme
por: Lee, Sang Y.
Publicado: (2016)

Recent Advances in Dual PI3K/mTOR Inhibitors for Tumour Treatment
por: Wu, Xianbo, et al.
Publicado: (2022)

IM-01 PI3K GAMMA INHIBITOR FOR OVERCOMING TREATMENT RESISTANCE IN COMBINATION THERAPY OF TEMOZOLOMIDE AND ANTI-PDL1 ANTIBODY FOR GLIOBLASTOMA PATIENTS
por: Ishikawa, Eiichi, et al.
Publicado: (2019)

Role of PI3K in the Progression and Regression of Atherosclerosis
por: Zhao, Yunyun, et al.
Publicado: (2021)

Investigation into the Role of PI3K and JAK3 Kinase Inhibitors in Murine Models of Asthma
por: Wagh, Akshaya D., et al.
Publicado: (2017)

Glycogenolysis in Acquired Glioma Resistance to Temozolomide: A Role for the [Ca(2+)](i)-dependent Activation of Na,K-ATPase/ERK(1/2) Signaling
por: Xu, Junnan, et al.
Publicado: (2018)

Targeting Noncanonical Pyroptosis With a Small Molecular Inhibitor Alleviates Inflammation in the LPS-Induced Keratitis Mouse Model
por: Zhang, Yun, et al.
Publicado: (2023)

The Protective Effect of New Compound XH-103 on Radiation-Induced GI Syndrome
por: Dong, Yinping, et al.
Publicado: (2018)

BYHWD Alleviates Inflammatory Response by NIK-Mediated Repression of the Noncanonical NF-κB Pathway During ICH Recovery
por: Xiao, Wei, et al.
Publicado: (2021)

Accelerated hyperfractionation plus temozolomide in glioblastoma
por: Kaul, David, et al.
Publicado: (2016)

Strategies of temozolomide in future glioblastoma treatment
por: Lee, Chooi Yeng
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_us5i38n7v2orj1rgejuqm2j87o